Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

NCT04217421 is registered in ClinicalTrials.gov with dr. M.J.N.L. Benders as lead sponsor.

NCT NCT04217421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04217421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Lead sponsor
dr. M.J.N.L. Benders
Phase
Phase 3
Overall status
Recruiting
Start date
February 14, 2020
Completion date
December 31, 2028
Enrollment
236 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

congenital heart disease in children, neuroprotection